PS
Poonam Shukla Chandra Kumar
About Poonam Shukla Chandra Kumar
Data last updated:
Poonam Shukla Chandra Kumar has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Gradewell Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Gradewell Pharmaceutical Private Limited at ₹23.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Apr 2018 | 2018 | ₹23.7 Lakh (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Poonam Shukla Chandra Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Poonam Shukla Chandra Kumar
Poonam Shukla Chandra Kumar has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Gradewell Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Gradewell Pharmaceutical Private Limited at ₹23.7 Lakh (FY 2025).
Poonam Shukla Chandra Kumar is associated with 1 company as Director, including Gradewell Pharmaceutical Private Limited (₹23.7 Lakh).
Poonam Shukla Chandra Kumar has expertise in General Business.
Poonam Shukla Chandra Kumar has 8 years in corporate governance.
By reported revenue, the largest current company of Poonam Shukla Chandra Kumar is Gradewell Pharmaceutical Private Limited, with revenue of ₹23.7 Lakh (FY 2025).
Poonam Shukla Chandra Kumar currently holds positions at 1 company: Gradewell Pharmaceutical Private Limited (₹23.7 Lakh).